Product Overview

The document appears to describe various formulations of a product named Singjoint®, produced by a company referred to as Al Products Co., Ltd. The product is available in multiple concentrations and volumes, specifically 10 mg/mL, 12 mg/mL, and 20 mg/mL, with volumes ranging from 1.0 mL to 3.0 mL. Each formulation is associated with a specific model number, such as ORT-SJ-10-1.0 for the 10 mg/mL at 1.0 mL volume.

Intended Use and Application

Singjoint® is intended for relief related to osteoarthritis (OA), likely through intra-articular injection to supplement synovial fluid in joints. The product aims to provide pain relief, protect joint cartilage, and restore joint function. The document suggests consulting healthcare professionals for appropriate diagnosis and treatment.

Key Points and Recommendations

• Multiple dosage options allow for tailored treatment based on patient needs.
• The product is designed to supplement or replace synovial fluid to improve joint mobility and reduce symptoms.
• Proper medical consultation is emphasized to confirm OA diagnosis and determine suitability of Singjoint® treatment.

Limitations and Missing Information

The document fragment lacks detailed specifications such as administration procedures, contraindications, side effects, storage conditions, and clinical data supporting efficacy. No tables, charts, or detailed procedural guidelines are included in the provided text.